Written by Baricitinib is a medication primarily used to treat moderate to severe rheumatoid arthritis (RA), a chronic inflammatory condition that affects the joints. It belongs to a class of drugs called Janus kinase (JAK) inhibitors. By inhibiting specific enzymes known as JAK1 and JAK2, Baricitinib disrupts the immune response that contributes to the inflammation and damage […]